Mylan Inc. (NASDAQ:MYL) announced the U.S. launch of its Lamivudine Tablets, 100 mg, which is the generic version of GlaxoSmithKline’s Epivir-HBV™. Mylan received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for this product, which is indicated for the treatment of chronic hepatitis B virus infection associated with evidence of hepatitis B viral replication and active liver inflammation. On Friday shares of Mylan, Inc. (NASDAQ:MYL) closed at $56.00. Company’s sales growth for last 5 years was 6.10% and EPS growth for next 5 years is recorded as 14.26%.
Charles Schwab Corporation (NYSE:SCHW) reported Q4 EPS of $0.24, in-line with the analyst estimate of $0.24. Revenue for the quarter came in at $1.55 billion versus the consensus estimate of $1.53 billion. The Charles Schwab Corporation (NYSE:SCHW) in last trading activity advanced 0.86% to close at $26.90. Company weekly performance is -5.45% while its quarterly performance stands at 5.70%. The Charles Schwab Corporation (NYSE:SCHW) is -13.06% away from its 52 week high.
Canon Inc. (NYSE:CAJ) again ranked first among Japanese companies and third overall for the number of U.S. patents awarded in 2014, according to the latest ranking of preliminary patent results issued by IFI CLAIMS Patent Services on January 12, 2015, according to Canon Inc. On last trading day Canon Inc. (NYSE:CAJ) advanced 0.25% to close at $32.27. Its volatility for the week is 1.17% while volatility for the month is 0.92%. CAJ’s sales growth for past 5 years was -1.80% and its EPS growth for past 5 years was -4.00%. Canon Inc. (NYSE:CAJ) monthly performance is 2.93%.
Home Properties, Inc. (NYSE:HME) on 6 January announced that its Baltimore area apartment communities received multiple awards for excellence during the 18th annual Star Awards, presented by the Maryland Multi-Housing Association, Inc. (MMHA). Home Properties owns and operates 23 MMHA-member communities in the Baltimore area. Home Properties Inc. (NYSE:HME) has 1.30% insider ownership while its institutional ownership stands at 93.50%. In last trading activity company’s stock closed at $72.65.
On last trading day Art’s-Way Manufacturing Co. Inc. (NASDAQ:ARTW) remains unchanged to close at $4.90. Its volatility for the week is 1.65% while volatility for the month is 2.33%. ARTW’s sales growth for past 5 years was 1.30% and its EPS growth for past 5 years was -3.70%. Art’s-Way Manufacturing Co. Inc. (NASDAQ:ARTW) monthly performance is -0.20%.